I hate the clickbait title, but the article is quite nice. Some cool things from the article:

While the drug is still being clinically trialled, early data has so far shown a 100% success rate against a specific variant of the disease

And

Early trials have shown the drug to be effective in treating 3% to 5% of bowel cancers which have a particular gene mutation.